As U.S. President Donald Trump takes aim at the mostly American-owned pharmaceutical factories that dot the Irish countryside ...

By Maggie Fick and Kashish Tandon LONDON/BENGALURU (Reuters) -Drugmaker stocks gained a temporary reprieve on Thursday as U.S. President Donald Trump spared pharmaceutical products from reciprocal ...

Major drugmakers were trading sharply lower on Tuesday as Wall Street is bracing for a broader set of tariffs that President ...

Leerink Partners analyst David Resinger warned his clients on Sunday that the tariff risks to the industry are ...

The talks between the administration and the industry, which have been taking place behind closed doors, have given some ...

Johnson & Johnson shares fell more than 3% on Tuesday after a U.S. bankruptcy judge rejected its $10 billion proposal to end ...

Merck & Co said on Thursday that it plans to launch a subcutaneously injected version of its blockbuster cancer immunotherapy ...

Top health care investment bankers say that large deals involving pharmaceutical and biotech companies are stalling as executives grapple with ...

Merck has signed a licensing agreement for a heart disease drug with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion, ...

Merck has signed a licensing deal with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion for its experimental heart ...

DURHAM, N.C.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today the opening of a new, $1 billion, 225,000-square-foot facility dedicated to ...

Mylan N.V. (MYL +0.5%) announces the U.S. commercial launch of perphenazine tablets, the generic version of Merck (NYSE:MRK)'s ...